0001171843-15-006650.txt : 20151204 0001171843-15-006650.hdr.sgml : 20151204 20151204205503 ACCESSION NUMBER: 0001171843-15-006650 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151201 FILED AS OF DATE: 20151204 DATE AS OF CHANGE: 20151204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PAETZOLD MARY E CENTRAL INDEX KEY: 0001247904 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 151271131 MAIL ADDRESS: STREET 1: C/O IMMUNOMEDICS INC STREET 2: 300 AMERICAN ROD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 4 1 gff4_paetzold120415.xml OWNERSHIP DOCUMENT X0306 4 2015-12-01 0 0000722830 IMMUNOMEDICS INC IMMU 0001247904 PAETZOLD MARY E C/O IMMUNOMEDICS, INC. 300 AMERICAN ROAD MORRIS PLAINS NJ 07950 1 0 0 0 Common Stock 2015-12-01 4 M 0 10000 1.59 A 65738 D Common Stock 2015-12-01 4 F 0 6262 3.17 D 59476 D Common Stock 2015-12-01 4 M 0 10664 A 70140 D Common Stock 2015-12-01 4 F 0 2666 D 67474 D Stock Options (right to buy) 1.59 2015-12-01 4 M 0 10000 0 D 2015-12-03 Common Stock, par value $0.01 per share 10000 0 D Restricted Stock Units 2015-12-01 4 M 0 10664 0 D Common Stock, par value $0.01 per share 10664 0 D Stock Options (right to buy) 3.11 2015-12-02 4 A 0 28821 0 A 2022-12-02 Common Stock, par value $0.01 per share 28821 28821 D Restricted Stock Units 2015-12-02 4 A 0 14469 0 A Common Stock, par value $0.01 per share 14469 14469 D Delivery of common stock upon vesting of restricted stock units granted on December 3, 2014. The number of shares withheld to satisfy the tax withholding obligation of the reporting person upon vesting of Restricted Stock Units is correlated with the reporting person's tax withholding percentage. The stock options are fully vested on the date of grant. Each restricted stock unit represents a contingent right to receive one share of Immunomedics, Inc. common stock. The restricted stock units shall vest upon the earlier of (i) the reporting person's completion of one year of service as a non-employee director from the date of grant, or (ii) the reporting person's continuation in service through the day immediately preceding the next annual stockholders meeting following the date of grant. /s/ Cynthia L. Sullivan, Attorney-In-Fact 2015-12-04